• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Intraop Medical Moves to a New 14,000 Square Foot Production Facility; Tripling Production and Testing Capacity

Posted on: Wednesday, 14 September 2005, 09:00 CDT

Intraop Medical (OTCBB:IOPM), manufacturer and developer of the Mobetron(R), an innovative machine used to deliver intraoperative radiation treatment (IORT) during cancer surgery, announces that it is moving to a new corporate headquarters and testing facility located in Sunnyvale, California. The new facility occupies over 14,000 square feet, more than tripling the Company's current capacity, and includes several rooms shielded for radiation. Although the Mobetron requires no additional room shielding while treating patients, shielded facilities are needed during the extensive testing of the system prior to shipping it to a customer.

Intraoperative Radiation Therapy (IORT) is the direct application of radiation to the tumor or tumor bed while a patient is undergoing surgery for cancer. A single two-minute IORT treatment can often eliminate several weeks of conventional pre- or post-operative external beam radiation therapy because the normal tissues surrounding the tumor can be displaced or protected while IORT is administered as part of the surgical procedure to remove the tumor.

Dr. Donald A. Goer, Chief Executive Officer, commented, "The ability to transition into a larger headquarters demonstrates the significant growth Intraop has experienced in the past six months and further demonstrates our company's ambitions for growth in the future. Our old headquarters had only one test cell that limited our ability to ship multiple Mobetron systems at a time. Our new facility now provides us with the testing space needed to ramp up production and meet our anticipated customer demand."

Rich Simon, Vice-President of Operations, said "This new facility will allow us to consolidate our engineering and testing activities, improving our efficiency and reducing the cost to test the Mobetron."

About Intraop Medical Corporation

Intraop Medical Corporation is improving the quality of life for cancer patients through the development, manufacturing and sales of its proprietary Mobetron system. The Mobetron is a mobile electron beam system designed for intraoperative radiation therapy (IORT) treatment of cancer, coronary/vascular restenosis and other medical applications. IORT is the direct application of radiation to a tumor while a patient is undergoing cancer surgery. Intraop Medical Corporation has revolutionized this procedure by developing the first mobile device for delivering IORT in the operating room without the necessity of adding extensive radiation shielding. The Mobetron is easily transportable between operating rooms and/or hospitals, further increasing system usage. The system is FDA approved for sale in the United States and has received the equivalent foreign approvals; CE Mark in Europe, JIS in Japan and SDA in China. Intraop Medical Corporation is based in Santa Clara, California. For more information on Intraop Medical Corporation please visit: www.intraopmedical.com.

This press release may contain "forward-looking statements" within the meaning of Section 27A of the 1933 Securities Act and Section 21E of the 1934 Securities Exchange Act. Actual results could differ materially, as the result of such factors as competition in the markets for the company's products and services and the ability of the company to execute its plans. By making these forward-looking statements, the company can give no assurances that transactions described in this press release will be successfully completed, and undertakes no obligation to update these statements for revisions or changes after the date of this press release.

Source: Business Wire

More News in this Category